QIAGEN N.V. / Share buy-back
17.12.2014 15:31
Dissemination of a Post-admission Duties announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Disclosure according to Art. 4 Para. 4 of the Regulation (EC) No. 2273/2003
QIAGEN N.V. Share Repurchase -
Completion of the second tranche
On September 22, 2014, QIAGEN N.V. disclosed pursuant to art. 4 para. 2 of
the Regulation (EC) no. 2273/2003 the beginning of a second tranche of the
share buyback program on September 22, 2014. The second tranche of the
buy-back program for the Euro-equivalent amount of up to USD 40 million was
completed on December 12, 2014.
The total number of shares which have been bought back within the framework
of the second tranche of the share repurchase program in the time period
from September 22, 2014 until and including December 12, 2014 amounts to
1,707,474 shares. The average purchase price per share was EUR 18.2278; a
total price of EUR 31,123,533.83 (excl. ancillary costs), which represents
based on the ECB reference rate as of September 19, 2014 a USD amount of
39,999,965.68, was paid to buy back the shares.
In a prior tranche the Company has in the time period between August 4 and
September 17, 2014 repurchased 410,562 shares.
The purchase of the shares of QIAGEN N.V. has been carried out by a
financial institution that has been commissioned by QIAGEN N.V.; the shares
were repurchased exclusively on the electronic trading platform of the
Frankfurt Stock Exchange (XETRA).
Further information regarding the transactions according to art. 4 para. 3
and 4 of the Regulation (EC) no. 2273/2003 is published on the website of
QIAGEN N.V. (www.qiagen.com).
We will report on the execution of further tranches of the buy-back program
in due course.
Venlo, 17 December 2014
The Managing Board
###
Contacts:
QIAGEN
Investor Relations
John Gilardi
+49 2103 29 11711
e-mail:ir@qiagen.com
Public Relations
Dr. Thomas Theuringer
+49 2103 29 11826
e-mail:pr@qiagen.com
17.12.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: QIAGEN N.V.
Spoorstraat 50
5911 KJ Venlo
Netherlands
Internet: www.qiagen.com
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-CMS: QIAGEN N.V.: Release of a capital market information
| Source: EQS Group AG